GLP-1RAs show added protection against cancer beyond weight reduction

[News]

New research being presented at this year's European Congress on Obesity (ECO) in Malaga, Spain (11-14 May) and published in the journal eClinicalMedicine finds that first generation weight-loss medications like liraglutide and exenatide appear to show anti-cancer benefits beyond weight loss.

More... (https://www.news-medical.net/news/20250511/GLP-1RAs-show-added-protection-against-cancer-beyond-weight-reduction.aspx)